0000-00-00 |
|
|
|
External link to document |
2020-11-11 |
13 |
SO ORDERED |
Stipulation to Substitute U.S. Patent No. RE48,286 for U.S. Patent No. 7,138,390. Signed by Judge Maryellen…2020
17 January 2023
1:20-cv-01215
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-11-19 |
17 |
Complaint - Amended |
the ’673 patent”); 10,047,117 (filed Nov. 20,
1
The RE286 Patent is a reissue of U.S. Patent No. 7,138,390…or Non-Infringement for U.S. Patent Nos.
7,138,390; 9,238,673; 10,047,117; 10,052,337; and 10,174,073 …073 patent”); and 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”)
(collectively the “patents-in-… 1. This action for patent infringement, brought pursuant to the patent laws of the
United States… expiration of U.S. Patent Nos. RE48,286 (filed June 21, 2019) (“the
RE286 patent”);1 9,238,673 (filed |
External link to document |
2020-11-19 |
18 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s)RE48,286; 9,238,673; 10,047,117; 10,052,…11 September 2020
1:20-cv-01215
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-09-10 |
4 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,…11 September 2020
1:20-cv-01215
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |